# CYP2B6 Polymorphisms in Methadone Disposition

> **NCT01648283** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 78 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** IV racemic methadone HCl
- **DRUG:** Oral racemic methadone HCl

## Key facts

- **NCT ID:** NCT01648283
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2015-03
- **Final completion:** 2015-06
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01648283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01648283, "CYP2B6 Polymorphisms in Methadone Disposition". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01648283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*